Abstract
Lovexair is a non-profit organization dedicated to the care, support and guidance of people with respiratory pathologies and to the support of healthcare professionals. Lovexair has developed the HappyAir Community, an ecosystem of clinical, educational and social resources for comprehensive patient care, well-being and a better quality of life. We report on the outcomes of events held in two Latin American countries (Colombia and Mexico) in late 2023, launching the HappyAir project in these communities through assessing the demographics, clinical and risk factors and outcomes of respiratory diseases on patients affected by these conditions. A total of 103 patients with respiratory problems were assessed, using spirometry, the exhaled nitric oxide test (FeNO), the COPD Assessment Test (CAT) and the Asthma Control Test. Only 22% of the study population showed abnormal spirometry, despite a prevalence of asthma and COPD of 39%. Conversely, the FeNO test was abnormal to the same extent as asthma was prevalent. This population also showed an association between BMI and dyspnoea. The subjects showed a high level of awareness on the effect of environmental pollution on their respiratory problems. The experience and results of this exercise will be used to inform and guide clinical and social interventions aiming to improve the prospects and quality of life in patients with chronic respiratory disorders. They should assist in identifying and addressing diagnostic and treatment gaps in communities suffering from respiratory illness.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study did not receive any funding
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
This study was approved by the ethics sub-committee of the Board of the Lovexair foundation (https://www.lovexair.com/en/consejo-asesor/) using the International Ethical Guidelines for Biomedical Research Involving Human Subjects (CIOMS 2016) and the Declaration of helsinki as guidance documents.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, University of Washington, and Vrije Universiteit Amsterdam.
Subject Area
Reviews and Context
0
Comment
0
TRIP Peer Reviews
0
Community Reviews
0
Automated Services
0
Blogs/Media
Author Videos